Journal article

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial

Toshiaki Ohkuma, Min Jun, Anthony Rodgers, Mark E Cooper, Paul Glasziou, Pavel Hamet, Stephen Harrap, Giuseppe Mancia, Michel Marre, Bruce Neal, Vlado Perkovic, Neil Poulter, Bryan Williams, Sophia Zoungas, John Chalmers, Mark Woodward

Hypertension | LIPPINCOTT WILLIAMS & WILKINS | Published : 2019

University of Melbourne Researchers


Funding Acknowledgements

The ADVANCE trial (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) was funded by the grants from the National Health and Medical Research Council (NHMRC) of Australia and Servier. T. Ohkuma is supported by the John Chalmers Clinical Research Fellowship of the George Institute. M. Jun is supported by a Scientia Fellowship from the University of New South Wales Sydney. B. Williams is a National Institute for Health Research (NIHR) Senior Investigator. M. Woodward is an NHMRC of Australia Principal Research Fellow (1080206).